(Q43480841)

23 November 2017

Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure (English)

1 reference

23 November 2017

1 reference

congestive heart failure

1 reference

R J Axelrod

1

1 reference

23 November 2017

T De Marco

2

1 reference

23 November 2017

M Dae

3

1 reference

23 November 2017

E H Botvinick

4

1 reference

23 November 2017

K Chatterjee

5

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 May 1987

1 reference

Journal of the American College of Cardiology

23 November 2017

1 reference

23 November 2017

9

1 reference

23 November 2017

5

1 reference

23 November 2017

1124-1130

1 reference

The role of vasodilator therapy in heart failure

23 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Reevaluation of digitalis efficacy. New light on an old leaf

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Hemodynamic assessment of amrinone. A new inotropic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Evaluation of a new bipyridine inotropic agent--milrinone--in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Acute dose range study of milrinone in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Intravenous and oral MDL 17043 (A new inotrope-vasodilator agent) in congestive heart failure: Hemodynamic and clinical evaluation in 38 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Mechanisms of improved left ventricular function following intravenous MDL 17,043 in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

MDL 17,043: short- and long-term cardiopulmonary and clinical effects in patients with heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Inotropic therapy for refractory congestive heart failure with oral fenoximone (MDL-17,043): poor long-term results despite early hemodynamic and clinical improvement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

Pericardial pressure assessed by right atrial pressure: a basis for calculation of left ventricular transmural pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2887%2980317-0

7 January 2021

10.1016/S0735-1097(87)80317-0

Identifiers

DOI

1 reference

23 November 2017

1 reference